Do calcifediol (vitamin D) and pyridoxine (vitamin B6) have any benefit for premenstrual syndrome (PMS) in adolescent girls?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No Clear Evidence for Calcifediol or Vitamin B6 in PMS for Adolescent Girls

Based on available evidence, neither calcifediol (vitamin D) nor pyridoxine (vitamin B6) can be definitively recommended for treating PMS in adolescent girls, as no high-quality guidelines or studies specifically address this population and indication.

Evidence Assessment

Vitamin D for PMS

The most relevant research comes from studies in young women (not specifically adolescents):

  • Vitamin D supplementation showed benefit for PMS-related mood symptoms in young women (15-21 years) with severe vitamin D deficiency (≤10 ng/mL), reducing anxiety, irritability, crying, and sadness scores significantly 1

  • A 2026 meta-analysis found vitamin D reduced total PMS severity (SMD: -0.78) and physical symptoms, but with "very low" certainty of evidence and substantial heterogeneity 2

  • Effects appear most pronounced in those with severe vitamin D deficiency 1, 3

Critical limitation: None of the available guidelines (PCOS, contraception, functional hypothalamic amenorrhea) address vitamin D or B6 for PMS treatment 4, 5, 6. The 2024 Endocrine Society vitamin D guideline focuses on diabetes prevention, not PMS 7.

Vitamin B6 for PMS

  • A 1989 trial showed modest benefit for emotional symptoms (depression, irritability, tiredness) at 50 mg/day, but no effect on other PMS symptoms 8

  • A 2020 trial comparing B6 (80 mg/day) to broad-spectrum micronutrients found both reduced PMS symptoms with medium effect sizes (ES = 0.43-0.56), with 60% achieving full remission 9

  • The 2023 ACOG guideline on premenstrual disorders 10 would be the most authoritative source, but the provided excerpt doesn't detail specific vitamin recommendations

Clinical Approach

When to Consider Supplementation

Screen for vitamin D deficiency first:

  • Check 25(OH)D levels in adolescent girls with PMS, particularly those with:
    • Limited sun exposure
    • Dark skin pigmentation
    • Restrictive diets
    • Obesity

If vitamin D deficiency is confirmed (25(OH)D <20 ng/mL):

  • Supplementation is reasonable based on research evidence 1, 3
  • Dosing: 50,000 IU every 2 weeks or equivalent daily dosing to achieve normal levels (30-60 ng/mL)
  • Monitor calcium levels to avoid hypercalcemia 11

For vitamin B6:

  • Consider 50-80 mg/day for emotional symptoms specifically (depression, irritability) 8, 9
  • Avoid doses >100 mg/day due to neuropathy risk
  • Effect size is modest and primarily for mood symptoms

Important Caveats

  1. First-line treatments remain unchanged: Hormonal contraceptives, NSAIDs, and lifestyle modifications are better-established interventions for PMS

  2. Adolescent-specific data is lacking: Most vitamin studies enrolled young adults, not adolescents specifically

  3. PMS vs. PMDD distinction matters: The micronutrient data suggests potentially larger effects for more severe symptoms (PMDD) 9

  4. Safety considerations:

    • Vitamin D: Monitor for hypercalcemia, especially with doses >4,000 IU/day 11
    • Vitamin B6: Doses >100 mg/day associated with peripheral neuropathy risk 12

Bottom Line

Vitamin D supplementation is reasonable if deficiency is documented, particularly for mood-related PMS symptoms in adolescent girls with 25(OH)D <20 ng/mL. Vitamin B6 (50-80 mg/day) may provide modest benefit for emotional symptoms but should not replace established first-line treatments. Neither should be used empirically without considering more evidence-based interventions first.

References

Guideline

contraception for adolescents.

Pediatrics, 2014

Guideline

vitamin d for the prevention of disease: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2024

Research

Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial.

The Journal of the Royal College of General Practitioners, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.